drugset / Trial / NCT01625000
Safety and Efficacy of MP-214 in Patients With Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to evaluate the efficacy, safety, and tolerability of MP-214 relative to placebo in patients with acute exacerbation of schizophrenia.
Timeline
- Start
- 2012-05
- Primary completion
- 2015-08
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cariprazine | Small molecule | 3 mg | Oral |
| Subject | Cariprazine | Small molecule | 6 mg | Oral |
| Subject | Cariprazine | Small molecule | 9 mg | Oral |
| Comparator | Risperidone | Other / unclassified | 4 mg | Oral |